FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "QuVa Pharma, Inc.(036662848)" | Labetalol Hydrochloride | 20 mg/4 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Lidocaine | 60000 mg/3000 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Lidocaine | 3334 mg/2000 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Lidocaine | 100 mg/5 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Lidocaine | 100 mg/10 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Lidocaine | 30000 mg/3000 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Lidocaine | 10 mg/100 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Morphine Sulfate | 30 mg/30 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Morphine Sulfate | 3000 mg/3000 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Neostigmine | 3000 mg/3000 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Neostigmine | 5 mg/5 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 16 mg/250 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 4 mg/250 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 3000 mg/3000 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 8 mg/250 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 20 U/1000 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 500000 U/500 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 20 U/1000 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 10020 U/3000 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 22500 U/2250 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 15000 U/1500 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 22500 U/2250 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 30 U/500 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 30 U/500 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 30 U/500 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(079937015)" | Phenylephrine Hydrochloride | 240 mg/3000 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(079937015)" | 70092-170 | 70092-170-05 | Phenylephrine Hydrochloride | 40 mg/250 mL | 2025-2 | valid | 2026-10-06 | ||
| "QuVa Pharma, Inc.(079937015)" | Phenylephrine Hydrochloride | 300 mg/3000 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(079937015)" | 70092-486 | 70092-486-46 | Phenylephrine Hydrochloride | 800 ug/10 mL | 2025-2 | valid | 2026-10-06 | ||
| "QuVa Pharma, Inc.(079937015)" | Phenylephrine Hydrochloride | 120 mg/3000 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(079937015)" | 70092-045 | 70092-045-05 | Phenylephrine Hydrochloride | 50 mg/250 mL | 2025-2 | valid | 2026-10-06 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-042 | 70092-042-05 | Phenylephrine Hydrochloride | 20 mg/250 mL | 2025-2 | valid | 2026-10-06 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-485 | 70092-485-46 | Phenylephrine Hydrochloride | 400 ug/10 mL | 2025-2 | valid | 2026-10-06 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-046 | 70092-046-46 | Phenylephrine Hydrochloride | 1000 ug/10 mL | 2025-2 | valid | 2026-10-06 | ||
| "QuVa Pharma, Inc.(079937015)" | Ropivacaine Hydrochloride | 6000 mg/3000 mL | 2025-2 | source_no_ndc | 2026-10-06 | ||||
| "QuVa Pharma, Inc.(079937015)" | 70092-588 | 70092-588-38 | Ropivacaine Hydrochloride | 1000 mg/500 mL | 2025-2 | valid | 2026-10-06 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-333 | 70092-333-75 | Ropivacaine Hydrochloride | 200 mg/100 mL | 2025-2 | valid | 2026-10-06 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-657 | 70092-657-76 | Ropivacaine Hydrochloride | 500 mg/250 mL | 2025-2 | valid | 2026-10-06 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-335 | 70092-335-76 | Ropivacaine Hydrochloride | 500 mg/250 mL | 2025-2 | valid | 2026-10-06 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-259 | 70092-259-75 | Ropivacaine Hydrochloride; Fentanyl Citrate | 200 mg/100 mL; 200 ug/100 mL | 2025-2 | valid | 2026-10-06 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-440 | 70092-440-76 | Ropivacaine Hydrochloride; Fentanyl Citrate | 400 mg/200 mL; 400 ug/200 mL | 2025-2 | valid | 2026-10-06 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-269 | 70092-269-37 | Bupivacaine Hydrochloride Anhydrous; Fentanyl Citrate | 156.25 mg/250 mL; 500 ug/250 mL | 2025-2 | valid | 2026-10-06 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-148 | 70092-148-43 | Trisodium Citrate Dihydrate | 120 mg/3 mL | 2025-2 | valid | 2026-10-06 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-692 | 70092-692-44 | Trisodium Citrate Dihydrate | 120 mg/3 mL | 2025-2 | valid | 2026-10-06 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-053 | 70092-053-05 | Vancomycin Hydrochloride | 1 g/250 mL | 2025-2 | valid | 2026-10-06 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-054 | 70092-054-05 | Vancomycin Hydrochloride | 1.25 g/250 mL | 2025-2 | valid | 2026-10-06 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-056 | 70092-056-05 | Vancomycin Hydrochloride | 1.5 g/250 mL | 2025-2 | valid | 2026-10-06 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-475 | 70092-475-50 | Dextrose Monohydrate | 25 g/50 mL | 2025-2 | valid | 2026-10-06 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-575 | 70092-575-36 | Diltiazem Hydrochloride | 125 mg/125 mL | 2025-2 | valid | 2026-10-06 | ||
| "QuVa Pharma, Inc.(079937015)" | 70092-007 | 70092-007-36 | Diltiazem Hydrochloride | 125 mg/125 mL | 2025-2 | valid | 2026-10-06 |